Skip to main content

Human VEGF (Research Grade Bevacizumab Biosimilar) Antibody

R&D Systems, Inc. a Bio-Techne Brand

Recombinant Monoclonal Antibody For Research Use Only
Cell Proliferation Induced by VEGF165and Neutralization by Human VEGF (Bevacizumab Biosimilar) Antibody.
Catalog #
Availability
Size / Price
Qty
Loading...
MAB9947-SP
MAB9947-100
Loading...
Setting the standard in quality research reagents

Key Product Details

Species Reactivity: Human
Immunogen: Human VEGF-A
Applications: Block/Neutralize
Label: Unconjugated
Source: Recombinant Monoclonal Human IgG1 Clone # Hu101
Specificity:

Detects human VEGF based on Bevacizumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Bevacizumab. This product is for research use only.

Citations for Human VEGF (Research Grade Bevacizumab Biosimilar) Antibody


Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.

FAQs for Human VEGF (Research Grade Bevacizumab Biosimilar) Antibody

  • Does this Biosimilar antibody have the same sequence as the therapeutic antibody?

    The Biosimilar antibody has the same variable region and constant region sequence as the therapeutic antibody.

  • What is a Biosimilar antibody?

    A Biosimilar antibody is a non-therpeutic, recombinantly-expressed antibody which has the same sequence as the corresponding therapeutic antibody.  It is for research use only. The nomenclature of the Biosimilar antibody includes the name of the therapeutic antibody.  For example, Catalog # MAB9577 is called Human EGFR (Research Grade CetuxiMab Biosimilar) antibody.

Product Documents for Human VEGF (Research Grade Bevacizumab Biosimilar) Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.